Granuloma faciale treated with topical dapsone: a case report

Dermatol Online J. 2014 Aug 17;20(8):13030/qt9q7520rx.

Abstract

Granuloma faciale (GF) is an unusual, treatment-resistant skin disorder that commonly affects the face. Several medical and surgical interventions are available that offer varying degrees of benefit. Both the condition and the treatment modalities can lead to significant disfigurement. The use of oral dapsone in the treatment of GF has been described in the literature, but there are no reports, to our knowledge, of the use of topical dapsone 5% gel (Aczone; Allergan Inc, Irvine, CA). We present a case of a patient with GF on the nasal tip successfully treated with topical dapsone.

Publication types

  • Case Reports

MeSH terms

  • Administration, Cutaneous
  • Anti-Infective Agents / administration & dosage
  • Biopsy
  • Dapsone / administration & dosage*
  • Diagnosis, Differential
  • Facial Dermatoses / drug therapy*
  • Facial Dermatoses / pathology
  • Granuloma / drug therapy*
  • Granuloma / pathology
  • Granuloma / prevention & control
  • Humans
  • Male
  • Middle Aged

Substances

  • Anti-Infective Agents
  • Dapsone